UNLOCKING THE VALUE OF RNAI Trademark

Trademark Overview

On Friday, August 13, 2010, a trademark application was filed for UNLOCKING THE VALUE OF RNAI with the United States Patent and Trademark Office. The USPTO has given the UNLOCKING THE VALUE OF RNAI trademark a serial number of 85976140. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, September 28, 2018. This trademark is owned by PhaseRx, Inc.. The UNLOCKING THE VALUE OF RNAI trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical and scientific research in the fields of pharmaceuticals, biologics, drug delivery and medical therapeutics; product research and development in the fields of pharmaceutical formulations of macromolecules, macromolecular pharmaceutical products, macromolecular therapeutics, and delivery of macromolecular therapeutics
unlocking the value of rnai

General Information

Serial Number85976140
Word MarkUNLOCKING THE VALUE OF RNAI
Filing DateFriday, August 13, 2010
Status710 - CANCELLED - SECTION 8
Status DateFriday, September 28, 2018
Registration Number4103250
Registration DateTuesday, February 21, 2012
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 3, 2011

Trademark Statements

Disclaimer with Predetermined Text"RNAI"
Goods and ServicesMedical and scientific research in the fields of pharmaceuticals, biologics, drug delivery and medical therapeutics; product research and development in the fields of pharmaceutical formulations of macromolecules, macromolecular pharmaceutical products, macromolecular therapeutics, and delivery of macromolecular therapeutics

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, September 28, 2018
Primary Code042
First Use Anywhere DateTuesday, January 11, 2011
First Use In Commerce DateTuesday, January 11, 2011

Trademark Owner History

Party NamePhaseRx, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSeattle, WA 98119
Party NamePhaseRx, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSeattle, WA 98119
Party NamePhaseRx, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSeattle, WA 98119

Trademark Events

Event DateEvent Description
Friday, September 28, 2018CANCELLED SEC. 8 (6-YR)
Tuesday, February 21, 2017COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, February 21, 2012REGISTERED-PRINCIPAL REGISTER
Wednesday, January 18, 2012NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, January 17, 2012LAW OFFICE REGISTRATION REVIEW COMPLETED
Friday, January 13, 2012ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, January 12, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 11, 2012STATEMENT OF USE PROCESSING COMPLETE
Wednesday, December 21, 2011USE AMENDMENT FILED
Wednesday, January 11, 2012DIVISIONAL PROCESSING COMPLETE
Wednesday, December 21, 2011DIVISIONAL REQUEST RECEIVED
Wednesday, January 11, 2012EXTENSION 1 GRANTED
Wednesday, December 21, 2011EXTENSION 1 FILED
Thursday, January 5, 2012CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, December 21, 2011TEAS STATEMENT OF USE RECEIVED
Wednesday, December 21, 2011TEAS REQUEST TO DIVIDE RECEIVED
Wednesday, December 21, 2011TEAS EXTENSION RECEIVED
Tuesday, June 28, 2011NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 3, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 3, 2011PUBLISHED FOR OPPOSITION
Tuesday, March 29, 2011LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, March 28, 2011ASSIGNED TO LIE
Tuesday, March 15, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, March 14, 2011EXAMINER'S AMENDMENT ENTERED
Monday, March 14, 2011NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, March 14, 2011EXAMINERS AMENDMENT E-MAILED
Monday, March 14, 2011EXAMINERS AMENDMENT -WRITTEN
Wednesday, February 16, 2011TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, February 15, 2011CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, February 15, 2011TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, December 5, 2010NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sunday, December 5, 2010NON-FINAL ACTION E-MAILED
Sunday, December 5, 2010NON-FINAL ACTION WRITTEN
Tuesday, November 30, 2010ASSIGNED TO EXAMINER
Wednesday, August 18, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, August 17, 2010NEW APPLICATION ENTERED IN TRAM

Related Keywords

rnai value unlocking therapeutics macromolecular medical pharmaceutical delivery fields research formulations macromolecules scientific